Michael
@ca480vbb.bsky.social
PhD in particle physics & former fellow at Erlangen Univ. / Max Planck Institute, battling a LC like illness since '19. 七転八起。#LongX #NDPH #POTS #Fibro #SFN #ME #PostVac. #BuyEU 🇪🇺🇺🇦
Pinned
Michael
@ca480vbb.bsky.social
· Nov 17
What's your first destination being healthy again?
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.
Reposted by Michael
Press release:
"protection [against #LongCovid] afforded by the vaccine primarily comes from preventing infection in the first place, rather than offering special protection against long COVID itself"
www.eurekalert.org/news-release...
Paper:
www.thelancet.com/journals/ecl...
#LongCovidKids
1/
"protection [against #LongCovid] afforded by the vaccine primarily comes from preventing infection in the first place, rather than offering special protection against long COVID itself"
www.eurekalert.org/news-release...
Paper:
www.thelancet.com/journals/ecl...
#LongCovidKids
1/
April 22, 2025 at 1:58 PM
Press release:
"protection [against #LongCovid] afforded by the vaccine primarily comes from preventing infection in the first place, rather than offering special protection against long COVID itself"
www.eurekalert.org/news-release...
Paper:
www.thelancet.com/journals/ecl...
#LongCovidKids
1/
"protection [against #LongCovid] afforded by the vaccine primarily comes from preventing infection in the first place, rather than offering special protection against long COVID itself"
www.eurekalert.org/news-release...
Paper:
www.thelancet.com/journals/ecl...
#LongCovidKids
1/
Now also on Mastodon: mastodon.social/@Ca480vbb
It seems the less US platforms the better. What a world we live in right now...
It seems the less US platforms the better. What a world we live in right now...
Michael 🇪🇺🇺🇦 (@Ca480vbb@mastodon.social)
0 Posts, 0 Following, 0 Followers · PhD in particle physics & former fellow at Erlangen Univ. / Max Planck Institute, battling a LC like illness since '19. 七転八起。#LongX #NDPH #POTS #Fibro #SFN #ME #Pos...
mastodon.social
February 28, 2025 at 10:36 PM
Now also on Mastodon: mastodon.social/@Ca480vbb
It seems the less US platforms the better. What a world we live in right now...
It seems the less US platforms the better. What a world we live in right now...
Results for the Fibromyalgia IgG reducer study:
"
showed statistically significant superiority to placebo, did not meet predefined criteria for progression. UCB decided not to pursue a Phase 3
"
Don't know what this means, sounds bad with no Phase 3.
www.ucb.com/newsroom/pre...
"
showed statistically significant superiority to placebo, did not meet predefined criteria for progression. UCB decided not to pursue a Phase 3
"
Don't know what this means, sounds bad with no Phase 3.
www.ucb.com/newsroom/pre...
On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth | UCB
On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth | UCB
www.ucb.com
February 27, 2025 at 8:51 PM
Results for the Fibromyalgia IgG reducer study:
"
showed statistically significant superiority to placebo, did not meet predefined criteria for progression. UCB decided not to pursue a Phase 3
"
Don't know what this means, sounds bad with no Phase 3.
www.ucb.com/newsroom/pre...
"
showed statistically significant superiority to placebo, did not meet predefined criteria for progression. UCB decided not to pursue a Phase 3
"
Don't know what this means, sounds bad with no Phase 3.
www.ucb.com/newsroom/pre...
It seems that the results of the IgG-reducer #Fibromyalgia study (clinicaltrials.gov/study/NCT056...) will be released no later than April 25th.
Results are scheduled to be reported on a conference:
efic2025.abstractserver.com/program/#/de...
Results are scheduled to be reported on a conference:
efic2025.abstractserver.com/program/#/de...
February 16, 2025 at 4:33 PM
It seems that the results of the IgG-reducer #Fibromyalgia study (clinicaltrials.gov/study/NCT056...) will be released no later than April 25th.
Results are scheduled to be reported on a conference:
efic2025.abstractserver.com/program/#/de...
Results are scheduled to be reported on a conference:
efic2025.abstractserver.com/program/#/de...
The novel pain medicine Suzetrigine has been approved by the FDA - the first one in over two decades.
It works by inhibiting the Na_v1.8 pathway.
Imo, worth a try for everyone with significant pain.
Unfortunately, approval for EU is not planned yet.
en.m.wikipedia.org/wiki/Suzetri...
#LongCovid
It works by inhibiting the Na_v1.8 pathway.
Imo, worth a try for everyone with significant pain.
Unfortunately, approval for EU is not planned yet.
en.m.wikipedia.org/wiki/Suzetri...
#LongCovid
Suzetrigine - Wikipedia
en.m.wikipedia.org
February 11, 2025 at 12:46 PM
The novel pain medicine Suzetrigine has been approved by the FDA - the first one in over two decades.
It works by inhibiting the Na_v1.8 pathway.
Imo, worth a try for everyone with significant pain.
Unfortunately, approval for EU is not planned yet.
en.m.wikipedia.org/wiki/Suzetri...
#LongCovid
It works by inhibiting the Na_v1.8 pathway.
Imo, worth a try for everyone with significant pain.
Unfortunately, approval for EU is not planned yet.
en.m.wikipedia.org/wiki/Suzetri...
#LongCovid
What's your first destination being healthy again?
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.
November 17, 2024 at 3:03 PM
What's your first destination being healthy again?
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.
#LifeAfterSickness
Mount Cook, 🇳🇿 , 2019.
Kayaking in Franconia, 2020.
Tateyama, 🇯🇵, 2019.
Bali, 🇮🇩, 2018.